Novo Nordisk’s recent move to set a $349 list price for brand‑name semaglutide — with a limited $199 introductory tier — changes the cost question for many Houston patients thinking about GLP‑1 therapy.
The TrumpRx drug price initiative has opened a new door to significantly lower out-of-pocket expenses for various GLP-1 weight loss medications, a change that directly impacts Houston residents seeking medical obesity treatments.
As interest in weight-loss medications grows, so does the temptation of “cheap” alternatives. Online ads promise fast results with compounded versions of Semaglutide and Tirzepatide — often at prices far below the brand-name drugs.
Discover how Zepbound, an FDA-approved weight loss injection, can help you manage obesity effectively in Houston.
Discover how TeleSlim Clinic Houston empowers patients with personalized, sustainable weight loss solutions through expert medical guidance and innovative virtual care.
